Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 3
2014 4
2015 2
2017 8
2018 12
2019 10
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

40 results
Results by year
Filters applied: . Clear all
Page 1
Clinical Therapeutic Strategy and Neuronal Mechanism Underlying Post-Traumatic Stress Disorder (PTSD).
Yabuki Y, Fukunaga K. Yabuki Y, et al. Int J Mol Sci. 2019 Jul 24;20(15):3614. doi: 10.3390/ijms20153614. Int J Mol Sci. 2019. PMID: 31344835 Free PMC article. Review.
Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome.
Shioda N, Yabuki Y, Yamaguchi K, Onozato M, Li Y, Kurosawa K, Tanabe H, Okamoto N, Era T, Sugiyama H, Wada T, Fukunaga K. Shioda N, et al. Among authors: yabuki y. Nat Med. 2018 Jun;24(6):802-813. doi: 10.1038/s41591-018-0018-6. Epub 2018 May 21. Nat Med. 2018. PMID: 29785027
SAK3-Induced Neuroprotection Is Mediated by Nicotinic Acetylcholine Receptors.
Fukunaga K, Yabuki Y. Fukunaga K, et al. Among authors: yabuki y. 2018 Apr 4. In: Akaike A, Shimohama S, Misu Y, editors. Nicotinic Acetylcholine Receptor Signaling in Neuroprotection [Internet]. Singapore: Springer; 2018. Chapter 9. Nicotinic Acetylcholine Receptor Signaling in Neuroprotection. 2018. PMID: 31314408 Free Books & Documents. Review.
[Neurological mechanism and therapeutic strategy for posttraumatic stress disorders].
Fukunaga K, Yabuki Y, Takahata I, Matsuo K. Fukunaga K, et al. Among authors: yabuki y. Nihon Yakurigaku Zasshi. 2018;152(4):194-201. doi: 10.1254/fpj.152.194. Nihon Yakurigaku Zasshi. 2018. PMID: 30298841 Review. Japanese.
Alzheimer's disease therapeutic candidate SAK3 is an enhancer of T-type calcium channels.
Fukunaga K, Izumi H, Yabuki Y, Shinoda Y, Shioda N, Han F. Fukunaga K, et al. Among authors: yabuki y. J Pharmacol Sci. 2019 Feb;139(2):51-58. doi: 10.1016/j.jphs.2018.11.014. Epub 2018 Dec 18. J Pharmacol Sci. 2019. PMID: 30600144 Free article. Review.
[The potential of G-quadruplexes as a therapeutic target for neurological diseases].
Shioda N, Yabuki Y, Asamitsu S. Shioda N, et al. Among authors: yabuki y. Nihon Yakurigaku Zasshi. 2019;154(6):294-300. doi: 10.1254/fpj.154.294. Nihon Yakurigaku Zasshi. 2019. PMID: 31787679 Review. Japanese.
Pharmacological prospects of G-quadruplexes for neurological diseases using porphyrins.
Asamitsu S, Yabuki Y, Ikenoshita S, Wada T, Shioda N. Asamitsu S, et al. Among authors: yabuki y. Biochem Biophys Res Commun. 2020 Oct 8;531(1):51-55. doi: 10.1016/j.bbrc.2020.01.054. Epub 2020 Jan 22. Biochem Biophys Res Commun. 2020. PMID: 31980177
Aberrant Amygdala-Dependent Cued Fear Memory in Na+/Ca2+ Exchanger 1 Heterozygous Mice.
Moriguchi S, Kita S, Inagaki R, Yabuki Y, Sasaki Y, Ishikawa S, Sakagami H, Iwamoto T, Fukunaga K. Moriguchi S, et al. Among authors: yabuki y. Mol Neurobiol. 2019 Jun;56(6):4381-4394. doi: 10.1007/s12035-018-1384-2. Epub 2018 Oct 15. Mol Neurobiol. 2019. PMID: 30324228
Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain.
Yabuki Y, Matsuo K, Kawahata I, Fukui N, Mizobata T, Kawata Y, Owada Y, Shioda N, Fukunaga K. Yabuki Y, et al. Int J Mol Sci. 2020 Mar 23;21(6):2230. doi: 10.3390/ijms21062230. Int J Mol Sci. 2020. PMID: 32210174 Free PMC article.
5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats.
Matsuo K, Yabuki Y, Fukunaga K. Matsuo K, et al. Among authors: yabuki y. Neuropharmacology. 2020 May 15;168:107975. doi: 10.1016/j.neuropharm.2020.107975. Epub 2020 Jan 25. Neuropharmacology. 2020. PMID: 31991146
40 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page